Beclometasone/formoterol

In this article, we will explore the impact of Beclometasone/formoterol on different aspects of today's society. Beclometasone/formoterol has become a topic of interest and debate in recent years, generating conflicting opinions and provoking various reactions in public opinion. Through in-depth analysis, we will examine how Beclometasone/formoterol has influenced culture, economics, politics, and other relevant fields. Additionally, we will discuss the short- and long-term implications of Beclometasone/formoterol, as well as possible prospects for the future. This article aims to provide a comprehensive and detailed view on Beclometasone/formoterol, highlighting its relevance in contemporary society.

Beclometasone/formoterol
Combination of
Beclometasone dipropionateGlucocorticoid
Formoterol fumarateLong-acting β2 agonist
Clinical data
Trade namesFostair
AHFS/Drugs.comInternational Drug Names
Routes of
administration		Inhalation
ATC code
Legal status
Legal status

Beclometasone/formoterol, sold under the brand name Fostair, is an inhalable fixed-dose combination drug for the treatment of asthma and chronic obstructive pulmonary disease (COPD).[1] It contains beclometasone dipropionate and formoterol fumarate dihydrate. It is inhaled.[1]

It was approved for medical use in the United Kingdom in 2007,[1] and in Australia in February 2020.[4][5] It is on the World Health Organization's List of Essential Medicines.[6]

References

  1. ^ a b c d "Fostair 100/6 micrograms per actuation pressurised inhalation solution - Summary of Product Characteristics (SmPC)". (emc). 3 March 2020. Retrieved 18 July 2020.
  2. ^ "Fostair 200/6 micrograms per actuation pressurised inhalation solution - Summary of Product Characteristics (SmPC)". (emc). 13 February 2019. Retrieved 18 July 2020.
  3. ^ "Fostair NEXThaler 200 micrograms/6 micrograms per actuation inhalation powder - Summary of Product Characteristics (SmPC)". (emc). 16 April 2019. Retrieved 18 July 2020.
  4. ^ "Australian Product Information - Fostair 100/6 (Beclometasone dipropionate and formoterol (eformoterol) fumarate dihydrate) pressurised inhalation solution". Therapeutic Goods Administration (TGA). April 2020. Retrieved 22 September 2020.
  5. ^ "AusPAR: Beclometasone dipropionate/formoterol (eformoterol) fumarate dihydrate". Therapeutic Goods Administration (TGA). 3 August 2020. Retrieved 22 September 2020.
  6. ^ World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.

Further reading

  • Foster K, Wong CY (July 2024). "Advances in inhaler therapy for asthma and chronic obstructive pulmonary disease: a comprehensive review of Fostair and Trimbow". Journal of Pharmacy and Pharmacology. doi:10.1093/jpp/rgae090. PMID 38954755.


Stub icon

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.

Wikious
Boobota
Sagapedia